1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA RP11-229P13.27 CTRPv2 pan-cancer AAC 0.094 0.009
mRNA C6orf226 CTRPv2 pan-cancer AAC -0.092 0.009
mRNA SERPINE2 CTRPv2 pan-cancer AAC 0.11 0.009
mRNA RDH8 CTRPv2 pan-cancer AAC 0.089 0.009
mRNA POLR2D CTRPv2 pan-cancer AAC -0.1 0.009
mRNA VPS4A CTRPv2 pan-cancer AAC -0.091 0.009
mRNA SELM CTRPv2 pan-cancer AAC -0.098 0.009
mRNA AC240274.1 CTRPv2 pan-cancer AAC -0.095 0.009
mRNA MPZ CTRPv2 pan-cancer AAC 0.099 0.009
mRNA TBC1D9 CTRPv2 pan-cancer AAC -0.095 0.009
Download CSV